Skip to main content

The Stakes Have Never Been Higher.

In the face of existential emergencies to humanity, Common Dreams is facing other potentially fatal threats to our funding model. Please support our nonprofit journalism and help us reach our $75,000 Mid-Year Campaign goal.

'Normal' is killing us.

Donald Trump is out of the White House. COVID-19 is fading, at least in wealthier nations. The world, they say, is returning to “normal.” That’s the narrative that the corporate media is selling. But there’s a problem: “normal” is destroying our planet, threatening our democracies, concentrating massive wealth in a tiny elite, and leaving billions of people without access to life-saving vaccines amid a deadly pandemic. Here at Common Dreams, we refuse to accept any of this as “normal.” Common Dreams just launched our Mid-Year Campaign to make sure we have the funding we need to keep the progressive, independent journalism of Common Dreams alive. Whatever you can afford—no amount is too large or too small—please donate today to support our nonprofit, people-powered journalism and help us meet our goal.

Please select a donation method:

Support Our Work -- Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Every donation—large or small—helps us bring you the news that matters.

For Immediate Release

Press Release

New GAO Study Finds U.S. Pays Two to Four Times More for Prescription Drugs than Other Nations

Sanders calls on President Biden to back negotiations with pharmaceutical companies to lower the outrageous price of prescription drugs in American Families Plan.
WASHINGTON -

Ahead of President Biden’s first address to a joint session of Congress and as his administration considers policies to lower drug prices, the U.S. Government Accountability Office (GAO) Wednesday released a report commissioned by Sen. Bernie Sanders (I-Vt.) finding that the U.S. pays more than two to four times higher prices for a selected sample of 20 single source, brand name drugs than Australia, Canada, and France. The result is that Americans suffering from blood clots, bronchitis, emphysema, and Hepatitis C pay vastly more for life-saving treatment than patients in other industrialized countries.

“This important GAO study confirms what we all already know: the pharmaceutical industry is ripping off the American people,” said Sen. Sanders. “The time is long overdue for the United States to do what every major country on earth does: negotiate with the pharmaceutical companies to lower the outrageous price of prescription drugs. I would urge the President to put this proposal in the American Families Plan and use the savings to expand and improve Medicare for older Americans. We can no longer tolerate the American people paying, by far, the highest prices in the world for prescription drugs.”

The study found that last year, the U.S. paid 4.36 times more than France, 4.25 times more than Australia, and 2.82 times more than Canada for the selected drugs, which represent a sample of the drugs with the highest Medicare Part D expenditures and use. The publicly available data for the comparison countries were gross prices that did not reflect potential discounts. As a result, the actual differences between U.S. prices and those of the other countries were likely much larger than GAO estimates.

While France and Australia operate universal, publicly funded health systems that include prescription drug coverage, both Canada and the U.S. have a significant number of people who do not have prescription drug coverage. But even when comparing the full cash retail prices of selected drugs, the prices quoted to individuals without prescription drug coverage, GAO found that prices were two to eight times higher in the U.S. than the same drugs from pharmacies in Canada. For example:

  • The cash price of Epclusa (28 tablets), which treats Hepatitis C, or an infection that attacks the liver, is $36,743 in the U.S. but $17,023.63 in Canada.
  • The cash price of Harvoni (28 tablets), which also treats Hepatitis C, is $46,570.33 in the U.S. but $19,084.54 in Canada
  • The cash price of Xarelto (30 tablets), which treats blood clots, is $558.33 in the U.S. but $85.44 in Canada
  • The cash price of Incruse Ellipta Inhalation Powder (30 inhalations), which treats chronic obstructive pulmonary disease (COPD), or a group of lung diseases which block airflow and make it difficult to breath, is $411.33 in the U.S. but $53.31 in Canada
  • The cash price of Anoro Ellipta Inhalation Powder (30 inhalations), which also treats COPD including bronchitis and emphysema, is $514.33 in the U.S. but $84.99 in Canada
    Source: Appendix V, Table 10 of report

Because France and Australia have universal health systems that cover prescription drugs, Australians would pay up to a $28.09 copay for a month supply of these medicines, while patients in France would pay anywhere from $0 to $34.03 for the drugs. The maximum copay that high income seniors with prescription drug coverage in Ontario, Canada would pay for the drugs is $4.67.

Read the full GAO study here.

Progressives Alarmed by Privatization Dub Infrastructure Deal a 'Disaster in the Making'

"Communities across the country have been ripped off by public-private schemes that enrich corporations and Wall Street investors and leave the rest of us to pick up the tab."

Jessica Corbett, staff writer ·


'We Must Not Stand Down': 270+ Arrested at Anti-Logging Protests in Canada

A battle over old-growth forests is raging in British Columbia.

Kenny Stancil, staff writer ·


US Lawmakers Demand EU 'Do the Right Thing or Get Out of the Way' on Covid-19 Vaccine Patent Waivers

"A global recovery requires a global response based on health needs—not Big Pharma," said Congressman Jesús "Chuy" García at a rally.

Brett Wilkins, staff writer ·


'Horrible and Unconscionable Betrayal': Biden DOJ Backs Trump Line 3 Approval

"You are siding with a handful of corrupt corporate elites over honoring treaty rights, climate, water, and the future of life on Earth."

Jessica Corbett, staff writer ·


'We Can't Wait': Thousands in DC Demand Bold Action on Climate, Immigration, and Jobs

"All of us have got to stand together and tell the billionaire class that our time is now," said Sen. Bernie Sanders.

Julia Conley, staff writer ·